Off-Label Promotion Ruling Presents Hidden Risks For Pharma Companies, Lawyers Say
Executive Summary
An appeals court ruling that bars prosecution solely for speech promoting off-label use carries with it potential negative ramifications for the pharmaceutical industry, including liability under state consumer protection laws and greater government scrutiny of internal marketing documents.